Cargando…

Retropubic radical prostatectomy: Clinicopathological observations and outcome analysis of 428 consecutive patients

AIM: We report the outcome analysis of retropubic radical prostatectomy (RRP) performed in 428 patients in terms of pathological findings, complications, and survival. MATERIALS AND METHODS: Systematically recorded case reports forms of consecutive 428 RRPs done over a 14-year period were analyzed u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Jagdeesh N., Singh, Dayal Partap, Bansal, Shweta, Makkar, Manisha, Valsangkar, Rohan, Siddaiah, Avinash T., Choudhary, Pushkar Sham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193733/
https://www.ncbi.nlm.nih.gov/pubmed/22022056
http://dx.doi.org/10.4103/0970-1591.85437
Descripción
Sumario:AIM: We report the outcome analysis of retropubic radical prostatectomy (RRP) performed in 428 patients in terms of pathological findings, complications, and survival. MATERIALS AND METHODS: Systematically recorded case reports forms of consecutive 428 RRPs done over a 14-year period were analyzed using the SPSS 14 software. Secondary analysis was done to evaluate era specific (pre and post 2002) changes in clinical features and survivals. RESULTS: Seven-year overall survival (OAS), cancer-specific survival (CSS), and event-free survival (EFS) was 83.2%, 82.8%, and 69.8% respectively in our series. Era-specific survival showed higher CSS post 2002, and there was an increase in presentation with organ-confined disease. Univariate and multivariate analysis showed statistically significant impact on era specific outcome. With the improvement in techniques decrease in complications rate and increase in quality of life was noted. CONCLUSIONS: Our series spanning over decade demonstrates that RRP is viable option to offer cure to organ-confined carcinoma prostate. Further, there is evidence of stage migration and improvements in outcome in post 2002 patients. Although our series is modest in number, the success rates and outcome data matches those reported in the literature.